论文信息 - The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group - 字舞流文

The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group

J. Sakamoto | M. Hino | S. Kimura | S. Morita | N. Iriyama | K. Ohashi | S. Hashino | C. Nakaseko | H. Takano | M. Uchiyama | H. Sakamaki | K. Inokuchi